Operationalisation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 trials in a low and lower-middle income critical care learning health system

Operationalisation of the Randomized Embedded Multifactorial Adaptive Platform for COVID-19 trials in a low and lower-middle income critical care learning health system

The Randomized Embedded Multifactorial Adaptive Platform (REMAP-CAP) adapted for COVID-19) trial is a global adaptive platform trial of hospitalised patients with COVID-19. We describe implementation in three countries under the umbrella of the Wellcome supported Low and Middle Income Country (LMIC)...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Aryal, D, Beane, A, Dondorp, A, Green, C, Haniffa, R, Hashmi, M, Jayakumar, D, Marshall, J, McArthur, C, Murthy, S, Webb, S, Acharya, S, Ishani, P, Jawad, I, Khanal, S, Koirala, K, Luitel, S, Pabasara, U, Paneru, HR, Kumar, A, Patel, SS, Ramakrishnan, N, Salahuddin, N, Shaikh, M, Tolppa, T, Udayanga, I, Umrani, Z
التنسيق: Journal article
اللغة:English
منشور في: F1000 Research 2021

مواد مشابهة